Seoul-based Hanmi Pharmaceutical Co. Ltd. will pay an undisclosed upfront fee and sales milestones, plus running percentage royalties on net sales, in return for development and marketing rights in South Korea and mainland China to Allegro Ophthalmics LLC's Luminate (ALG-1001).
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?